Arquivos do dia: Março 31, 2022
[Preprint] Estudo de coorte retrospectiva | 2º reforço de vacina e mortalidade por Covid-19 em adultos de 60 a 100 anos de idade.
31 Mar, 2022 | 13:44hSecond Booster Vaccine and Covid-19 Mortality in Adults 60 to 100 Years Old – Research Square
Comentários:
Huge Study Finds Second COVID-19 Booster is ‘Life-saving’ for Over 60s – Health Policy Watch
Fourth COVID-19 vaccine dose substantially reduces mortality in the elderly – News Medical
EUA aprovam 2ª dose de reforço contra Covid-19 para pessoas de 50 anos de idade ou mais e indivíduos imunocomprometidos.
31 Mar, 2022 | 13:41hU.S. approves second Covid-19 booster for people 50 and older – STAT
FDA OKs second COVID booster shot for older Americans – CIDRAP
Estudo de coorte | Desfechos de curto prazo da monoterapia com corticosteroide na síndrome inflamatória multissistêmica em crianças.
31 Mar, 2022 | 13:40h
Comentário no Twitter
In this study, corticosteroid monotherapy successfully treated a subset of patients with mild multisystem inflammatory syndrome in children. https://t.co/fuhHeBSaRp
— JAMA Pediatrics (@JAMAPediatrics) March 28, 2022
Estudo RECOVERY – 2 anos.
31 Mar, 2022 | 13:38hThe RECOVERY Trial – two years on – University of Oxford
Conteúdos relacionados:
[Preprint] RECOVERY trial shows Baricitinib reduces deaths in patients hospitalized with COVID-19.
RECOVERY Trial: No benefit from convalescent plasma in patients admitted to hospital with COVID-19.
RECOVERY trial: Azithromycin not beneficial for patients admitted to hospital with COVID-19
RECOVERY trial: Effect of hydroxychloroquine in hospitalized patients with Covid-19
Randomized trial: Lopinavir–ritonavir not beneficial for patients admitted to hospital with COVID-19
Comentário no Twitter
"One trial. Over 47,000 participants. Nearly 200 hospital sites, across six countries. Ten results. Four effective COVID-19 treatments. And behind them all, an army of researchers, doctors, nurses, statisticians and supporting staff."https://t.co/cDlCUkG4cD
— Martin Landray (@MartinLandray) March 28, 2022
Relato de caso | Os danos da antibioticoprofilaxia pós-operatória.
31 Mar, 2022 | 13:36hThe Harms of Postoperative Antibiotic Prophylaxis: A Teachable Moment – JAMA Internal Medicine (gratuito por tempo limitado)
Bacteriemia por S. aureus complicada e não complicada: uma pesquisa internacional Delphi entre especialistas em doenças infecciosas sobre definições e tratamento.
31 Mar, 2022 | 13:34hPosicionamento científico AHA/ASA | Tratamento endovascular e trombólise para AVC isquêmico agudo em pacientes com incapacidade premórbida ou demência.
31 Mar, 2022 | 13:32hComunicado de imprensa: Stroke treatments safe and effective for people with existing disability or dementia – American Heart Association
Comentário no Twitter (fio – clique para saber mais)
1/ Endovascular Treatment and Thrombolysis for Acute Ischemic Stroke in Patients with Pre-morbid Disability or Dementia
Authors: @draravindganesh @pecouille @SMGreenbergNeur @Doctorjfred @mayank_G0 @NAsdaghi @GPerue
Published today in @StrokeAHA_ASA: https://t.co/9VdIvGDNoN pic.twitter.com/CgET4ygCHu
— AHA Science (@AHAScience) March 28, 2022
Estudo mostra que é comum o excesso de tratamento em pacientes com diabetes tipo 2 residentes em casas de repouso.
31 Mar, 2022 | 13:30hComentários:
Overtreatment of T2DM Common Among VA Nursing Home Residents – HealthDay
Diabetes treatment deintensification uncommon in nursing home residents – medwire News
M-A | Anormalidades do parênquima pulmonar após internação por COVID-19 e pneumonite viral.
31 Mar, 2022 | 13:29hAnálise sistemática para o Global Burden of Disease 2019 Study | Impacto global, regional e nacional de doenças e lesões para adultos de 70 anos de idade ou mais.
31 Mar, 2022 | 13:27h
Comentário no Twitter
See our new paper prepared within @IHME_UW! #BMJ
Life expectancy ≥70 has continued to rise globally. #Disability burden remained constant, suggesting the need to enhance public health and intervention programmes to improve wellbeing among older adults.https://t.co/TegmWQ3048
— Maciej Banach (@maciejbanach) March 14, 2022